Study on the Relationship Between Plasma Nitrite and Nitrate Level and Salt Sensitivity in Human Hypertension Modulation of Nitric Oxide Synthesis by Salt Intake

Background —High salt intake suppresses the effect of nitric oxide (NO) in the peripheral resistance vessels in animal models. We tested the hypothesis that the modulation of endogenous NO is related to salt sensitivity in human hypertension. Methods and Results —Inpatients with essential hypertensi...

Full description

Saved in:
Bibliographic Details
Published inCirculation (New York, N.Y.) Vol. 101; no. 8; pp. 856 - 861
Main Authors Fujiwara, Naoto, Osanai, Tomohiro, Kamada, Takaatsu, Katoh, Takeshi, Takahashi, Koki, Okumura, Ken
Format Journal Article
LanguageEnglish
Published Hagerstown, MD Lippincott Williams & Wilkins 29.02.2000
American Heart Association, Inc
Subjects
Online AccessGet full text
ISSN0009-7322
1524-4539
1524-4539
DOI10.1161/01.CIR.101.8.856

Cover

Abstract Background —High salt intake suppresses the effect of nitric oxide (NO) in the peripheral resistance vessels in animal models. We tested the hypothesis that the modulation of endogenous NO is related to salt sensitivity in human hypertension. Methods and Results —Inpatients with essential hypertension (n=24) were maintained on a normal-salt diet (12 g/d NaCl) for 3 days, a low-salt diet (2 g), a high-salt diet (20 to 23 g), and a low-salt diet for 7 days. Normotensive subjects (n=16) were maintained on the first 2 salt diets. The hypertensive patients whose average 24-hour blood pressure was increased by >5% by salt loading were assigned to group 1 (n=8) and the others to group 2 (n=16). Nitrate plus nitrite (NO x ) was measured by the Griess method, and asymmetrical dimethylarginine (ADMA) by high-performance liquid chromatography. The plasma NO x level during the normal-salt diet was lower in group 1 than in group 2 and the normotensive group. After salt loading, the plasma NO x level was decreased and reversed after the second salt restriction. Plasma ADMA level was increased after salt loading and decreased after salt restriction. The change in plasma NO x level was correlated inversely with those in blood pressure ( r =−0.59, P =0.0007) and plasma ADMA level ( r =−0.64, P =0.003) after salt loading and restriction. Conclusions —Modulation of NO synthesis by salt intake may be involved in a mechanism for salt sensitivity in human hypertension, presumably via the change in ADMA.
AbstractList High salt intake suppresses the effect of nitric oxide (NO) in the peripheral resistance vessels in animal models. We tested the hypothesis that the modulation of endogenous NO is related to salt sensitivity in human hypertension.BACKGROUNDHigh salt intake suppresses the effect of nitric oxide (NO) in the peripheral resistance vessels in animal models. We tested the hypothesis that the modulation of endogenous NO is related to salt sensitivity in human hypertension.Inpatients with essential hypertension (n=24) were maintained on a normal-salt diet (12 g/d NaCl) for 3 days, a low-salt diet (2 g), a high-salt diet (20 to 23 g), and a low-salt diet for 7 days. Normotensive subjects (n=16) were maintained on the first 2 salt diets. The hypertensive patients whose average 24-hour blood pressure was increased by >5% by salt loading were assigned to group 1 (n=8) and the others to group 2 (n=16). Nitrate plus nitrite (NO(x)) was measured by the Griess method, and asymmetrical dimethylarginine (ADMA) by high-performance liquid chromatography. The plasma NO(x) level during the normal-salt diet was lower in group 1 than in group 2 and the normotensive group. After salt loading, the plasma NO(x) level was decreased and reversed after the second salt restriction. Plasma ADMA level was increased after salt loading and decreased after salt restriction. The change in plasma NO(x) level was correlated inversely with those in blood pressure (r=-0.59, P=0.0007) and plasma ADMA level (r=-0.64, P=0.003) after salt loading and restriction.METHODS AND RESULTSInpatients with essential hypertension (n=24) were maintained on a normal-salt diet (12 g/d NaCl) for 3 days, a low-salt diet (2 g), a high-salt diet (20 to 23 g), and a low-salt diet for 7 days. Normotensive subjects (n=16) were maintained on the first 2 salt diets. The hypertensive patients whose average 24-hour blood pressure was increased by >5% by salt loading were assigned to group 1 (n=8) and the others to group 2 (n=16). Nitrate plus nitrite (NO(x)) was measured by the Griess method, and asymmetrical dimethylarginine (ADMA) by high-performance liquid chromatography. The plasma NO(x) level during the normal-salt diet was lower in group 1 than in group 2 and the normotensive group. After salt loading, the plasma NO(x) level was decreased and reversed after the second salt restriction. Plasma ADMA level was increased after salt loading and decreased after salt restriction. The change in plasma NO(x) level was correlated inversely with those in blood pressure (r=-0.59, P=0.0007) and plasma ADMA level (r=-0.64, P=0.003) after salt loading and restriction.Modulation of NO synthesis by salt intake may be involved in a mechanism for salt sensitivity in human hypertension, presumably via the change in ADMA.CONCLUSIONSModulation of NO synthesis by salt intake may be involved in a mechanism for salt sensitivity in human hypertension, presumably via the change in ADMA.
High salt intake suppresses the effect of nitric oxide (NO) in the peripheral resistance vessels in animal models. We tested the hypothesis that the modulation of endogenous NO is related to salt sensitivity in human hypertension. Inpatients with essential hypertension (n=24) were maintained on a normal-salt diet (12 g/d NaCl) for 3 days, a low-salt diet (2 g), a high-salt diet (20 to 23 g), and a low-salt diet for 7 days. Normotensive subjects (n=16) were maintained on the first 2 salt diets. The hypertensive patients whose average 24-hour blood pressure was increased by >5% by salt loading were assigned to group 1 (n=8) and the others to group 2 (n=16). Nitrate plus nitrite (NO(x)) was measured by the Griess method, and asymmetrical dimethylarginine (ADMA) by high-performance liquid chromatography. The plasma NO(x) level during the normal-salt diet was lower in group 1 than in group 2 and the normotensive group. After salt loading, the plasma NO(x) level was decreased and reversed after the second salt restriction. Plasma ADMA level was increased after salt loading and decreased after salt restriction. The change in plasma NO(x) level was correlated inversely with those in blood pressure (r=-0.59, P=0.0007) and plasma ADMA level (r=-0.64, P=0.003) after salt loading and restriction. Modulation of NO synthesis by salt intake may be involved in a mechanism for salt sensitivity in human hypertension, presumably via the change in ADMA.
Background —High salt intake suppresses the effect of nitric oxide (NO) in the peripheral resistance vessels in animal models. We tested the hypothesis that the modulation of endogenous NO is related to salt sensitivity in human hypertension. Methods and Results —Inpatients with essential hypertension (n=24) were maintained on a normal-salt diet (12 g/d NaCl) for 3 days, a low-salt diet (2 g), a high-salt diet (20 to 23 g), and a low-salt diet for 7 days. Normotensive subjects (n=16) were maintained on the first 2 salt diets. The hypertensive patients whose average 24-hour blood pressure was increased by >5% by salt loading were assigned to group 1 (n=8) and the others to group 2 (n=16). Nitrate plus nitrite (NO x ) was measured by the Griess method, and asymmetrical dimethylarginine (ADMA) by high-performance liquid chromatography. The plasma NO x level during the normal-salt diet was lower in group 1 than in group 2 and the normotensive group. After salt loading, the plasma NO x level was decreased and reversed after the second salt restriction. Plasma ADMA level was increased after salt loading and decreased after salt restriction. The change in plasma NO x level was correlated inversely with those in blood pressure ( r =−0.59, P =0.0007) and plasma ADMA level ( r =−0.64, P =0.003) after salt loading and restriction. Conclusions —Modulation of NO synthesis by salt intake may be involved in a mechanism for salt sensitivity in human hypertension, presumably via the change in ADMA.
BACKGROUND: High salt intake suppresses the effect of nitric oxide (NO) in the peripheral resistance vessels in animal models. We tested the hypothesis that the modulation of endogenous NO is related to salt sensitivity in human hypertension. METHODS AND RESULTS: Inpatients with essential hypertension (n=24) were maintained on a normal-salt diet (12 g/d NaCl) for 3 days, a low-salt diet (2 g), a high-salt diet (20 to 23 g), and a low-salt diet for 7 days. Normotensive subjects (n=16) were maintained on the first 2 salt diets. The hypertensive patients whose average 24-hour blood pressure was increased by >5% by salt loading were assigned to group 1 (n=8) and the others to group 2 (n=16). Nitrate plus nitrite (NO(x)) was measured by the Griess method, and asymmetrical dimethylarginine (ADMA) by high-performance liquid chromatography. The plasma NO(x) level during the normal-salt diet was lower in group 1 than in group 2 and the normotensive group. After salt loading, the plasma NO(x) level was decreased and reversed after the second salt restriction. Plasma ADMA level was increased after salt loading and decreased after salt restriction. The change in plasma NO(x) level was correlated inversely with those in blood pressure (r=-0.59, P=0.0007) and plasma ADMA level (r=-0.64, P=0.003) after salt loading and restriction. CONCLUSIONS: Modulation of NO synthesis by salt intake may be involved in a mechanism for salt sensitivity in human hypertension, presumably via the change in ADMA.
Author Osanai, Tomohiro
Katoh, Takeshi
Fujiwara, Naoto
Kamada, Takaatsu
Takahashi, Koki
Okumura, Ken
Author_xml – sequence: 1
  givenname: Naoto
  surname: Fujiwara
  fullname: Fujiwara, Naoto
  organization: From the Second Department of Internal Medicine, Hirosaki University School of Medicine, Hirosaki, Japan
– sequence: 2
  givenname: Tomohiro
  surname: Osanai
  fullname: Osanai, Tomohiro
  organization: From the Second Department of Internal Medicine, Hirosaki University School of Medicine, Hirosaki, Japan
– sequence: 3
  givenname: Takaatsu
  surname: Kamada
  fullname: Kamada, Takaatsu
  organization: From the Second Department of Internal Medicine, Hirosaki University School of Medicine, Hirosaki, Japan
– sequence: 4
  givenname: Takeshi
  surname: Katoh
  fullname: Katoh, Takeshi
  organization: From the Second Department of Internal Medicine, Hirosaki University School of Medicine, Hirosaki, Japan
– sequence: 5
  givenname: Koki
  surname: Takahashi
  fullname: Takahashi, Koki
  organization: From the Second Department of Internal Medicine, Hirosaki University School of Medicine, Hirosaki, Japan
– sequence: 6
  givenname: Ken
  surname: Okumura
  fullname: Okumura, Ken
  organization: From the Second Department of Internal Medicine, Hirosaki University School of Medicine, Hirosaki, Japan
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1284313$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/10694524$$D View this record in MEDLINE/PubMed
BookMark eNp1kV1rFDEUhoNU7LZ675UEEe9mzedMcqmLtYVFpavXIZs5Q1MymTXJVPbfN92uFAre5HzkOYfD-56hkzhFQOgtJUtKW_qJ0OXq6npJa1RLJdsXaEElE42QXJ-gBSFENx1n7BSd5Xxby5Z38hU6paTVooILNG7K3O_xFHG5AXwNwRY_xXzjd_gLlL8AEf8MNo8Wf_cl-QLYxv6Q25qv4Q7CobOxoeANxOyLv_Nlj33El_No67vfQSoPP1N8jV4ONmR4c4zn6PfF11-ry2b949vV6vO6cVyz0mjlmLaOU9L3ijpnycCc6EB1ICSV0mklWnBu66gdnHaEyt4pzanglNmt4ufo4-PeXZr-zJCLGX12EIKNMM3ZdERLLdqugu-fgbfTnGK9zTDKOtm1glXo3RGatyP0Zpf8aNPe_FOxAh-OgM3OhiHZ6Hx-4piqh_GKtY-YS1POCQbjfDnoXdX0oe4zD64aQk11tZbUKFNdrYPk2eDTCf8ZuQd__aPY
CODEN CIRCAZ
CitedBy_id crossref_primary_10_1046_j_1365_2362_2003_01150_x
crossref_primary_10_3346_jkms_2010_25_1_16
crossref_primary_10_1016_j_aogh_2013_12_007
crossref_primary_10_1007_s11883_001_0068_x
crossref_primary_10_1111_j_1365_2362_2005_01457_x
crossref_primary_10_1253_circj_69_1380
crossref_primary_10_1042_CS20210566
crossref_primary_10_1016_j_amjcard_2017_06_036
crossref_primary_10_1016_j_lab_2006_03_005
crossref_primary_10_1111_j_1472_8206_2006_00406_x
crossref_primary_10_1067_mtc_2000_109537
crossref_primary_10_54393_pjhs_v4i12_1198
crossref_primary_10_1038_s41440_018_0122_5
crossref_primary_10_1016_j_jacc_2014_11_025
crossref_primary_10_1016_j_regpep_2012_12_007
crossref_primary_10_1016_j_niox_2017_11_005
crossref_primary_10_1152_ajprenal_90729_2008
crossref_primary_10_1016_j_jare_2018_01_002
crossref_primary_10_1038_jhh_2011_13
crossref_primary_10_3892_mmr_2016_5241
crossref_primary_10_1007_s00228_005_0010_1
crossref_primary_10_1097_HJH_0b013e328363c769
crossref_primary_10_1016_j_mehy_2003_11_008
crossref_primary_10_1177_039139880803100303
crossref_primary_10_1124_pr_55_2_3
crossref_primary_10_1016_j_atherosclerosis_2013_10_032
crossref_primary_10_1097_01_hjh_0000217839_26971_8d
crossref_primary_10_1113_expphysiol_2011_058404
crossref_primary_10_3945_ajcn_114_105197
crossref_primary_10_1016_j_ijcard_2008_10_007
crossref_primary_10_1191_1358863x05vm598oa
crossref_primary_10_1016_S1889_1837_02_71215_4
crossref_primary_10_1191_1358863x04vm538oa
crossref_primary_10_1097_HJH_0000000000001458
crossref_primary_10_1111_j_1525_139X_2009_00642_x
crossref_primary_10_1016_S0022_3565_24_29452_0
crossref_primary_10_1038_ki_2009_490
crossref_primary_10_1016_j_ehj_2011_09_004
crossref_primary_10_1038_sj_ejcn_1601766
crossref_primary_10_1046_j_1365_2362_2003_01184_x
crossref_primary_10_3390_ph3040940
crossref_primary_10_1111_j_1440_1797_2012_01659_x
crossref_primary_10_1016_j_atherosclerosis_2013_11_078
crossref_primary_10_1186_s12944_016_0226_3
crossref_primary_10_1067_mlc_2001_117556
crossref_primary_10_3945_ajcn_110_006155
crossref_primary_10_1016_j_nut_2011_08_018
crossref_primary_10_1152_ajprenal_00388_2002
crossref_primary_10_1046_j_1523_1755_2001_59780009_x
crossref_primary_10_1177_147323000903700404
crossref_primary_10_1016_j_atherosclerosis_2007_12_010
crossref_primary_10_1016_j_jacc_2006_10_068
crossref_primary_10_1186_s12882_024_03495_0
crossref_primary_10_1056_NEJMra064486
crossref_primary_10_1038_s41440_018_0098_1
crossref_primary_10_1038_sj_ejcn_1601553
crossref_primary_10_1016_S1769_7255_07_80022_8
crossref_primary_10_1046_j_1440_1681_2001_03533_x
crossref_primary_10_3346_jkms_2013_28_7_1034
crossref_primary_10_1111_j_1525_139X_2009_00606_x
crossref_primary_10_1097_00004872_200310000_00021
crossref_primary_10_3945_jn_108_097451
crossref_primary_10_1016_S0716_8640_10_70566_6
crossref_primary_10_1038_sj_ki_5000417
crossref_primary_10_18705_1607_419X_2007_13_2_119_127
crossref_primary_10_3109_09637486_2015_1042841
crossref_primary_10_1097_00001573_200007000_00008
crossref_primary_10_1097_00004872_200307000_00023
crossref_primary_10_1016_j_ccl_2005_03_003
crossref_primary_10_1016_S0899_9007_00_00586_4
crossref_primary_10_1007_s12038_011_9097_y
crossref_primary_10_1113_expphysiol_2005_032995
crossref_primary_10_1210_jc_2004_2045
crossref_primary_10_1053_j_ajkd_2005_05_009
crossref_primary_10_1053_j_ajkd_2009_12_022
crossref_primary_10_1074_jbc_M411226200
crossref_primary_10_1016_j_aca_2007_10_033
crossref_primary_10_3390_ijms14048062
crossref_primary_10_1291_hypres_28_255
crossref_primary_10_1111_bph_12291
crossref_primary_10_3389_fphys_2015_00150
crossref_primary_10_1038_clpt_2010_116
crossref_primary_10_1113_EP090714
crossref_primary_10_1517_13543784_2014_934808
crossref_primary_10_1016_S0003_2697_03_00157_X
crossref_primary_10_1177_1358836X0501000103
crossref_primary_10_1016_j_amjcard_2018_07_048
crossref_primary_10_1152_japplphysiol_00917_2010
crossref_primary_10_1097_00041552_200203000_00009
crossref_primary_10_1016_j_ijcard_2019_07_062
crossref_primary_10_3390_nu13041162
crossref_primary_10_1007_s00380_007_1017_6
crossref_primary_10_1186_s12890_015_0045_8
crossref_primary_10_1681_ASN_2014050430
crossref_primary_10_1016_j_tet_2011_01_054
crossref_primary_10_1007_s00726_015_2017_y
crossref_primary_10_1016_j_jash_2013_09_003
crossref_primary_10_1016_j_mehy_2003_11_043
crossref_primary_10_1097_00004872_200307000_00009
crossref_primary_10_5402_2013_481595
crossref_primary_10_1016_j_numecd_2015_09_008
crossref_primary_10_1111_jch_13852
crossref_primary_10_1016_S0735_1097_02_01781_3
crossref_primary_10_1161_JAHA_117_005653
crossref_primary_10_2174_1573396317999210111200222
crossref_primary_10_1016_j_niox_2017_04_002
crossref_primary_10_1111_j_1524_6175_2002_00503_x
crossref_primary_10_1152_ajpregu_90506_2008
crossref_primary_10_1016_j_jtbi_2007_12_023
crossref_primary_10_1093_ndt_gfr092
crossref_primary_10_1038_hr_2013_102
crossref_primary_10_1097_00004872_200312000_00021
crossref_primary_10_1161_HYPERTENSIONAHA_111_170175
crossref_primary_10_1080_10408398_2010_499824
crossref_primary_10_1063_1_2176616
crossref_primary_10_1093_ndt_16_3_452
crossref_primary_10_1097_00004872_200301000_00025
crossref_primary_10_1097_HJH_0b013e328341d19e
crossref_primary_10_1097_MNH_0000000000000394
crossref_primary_10_1097_01_jom_0000128158_32391_85
crossref_primary_10_1038_jhh_2009_32
crossref_primary_10_3945_ajcn_2008_26856
crossref_primary_10_1186_s12882_018_0997_z
crossref_primary_10_1016_j_cca_2015_05_011
crossref_primary_10_1038_aps_2011_72
crossref_primary_10_3390_ijms20153668
crossref_primary_10_1038_s41440_021_00741_y
crossref_primary_10_1097_HJH_0000000000002015
crossref_primary_10_1186_s13075_021_02479_x
crossref_primary_10_1097_MD_0000000000006065
crossref_primary_10_1016_j_jjcc_2018_02_003
crossref_primary_10_1111_j_1751_7176_2008_08575_x
crossref_primary_10_1038_jhh_2015_79
crossref_primary_10_1097_01_mnh_0000222701_22583_e8
crossref_primary_10_1038_ajh_2008_346
crossref_primary_10_1046_j_1523_1755_2003_00334_x
crossref_primary_10_1016_j_ehj_2015_12_003
crossref_primary_10_1016_S1769_7255_07_80634_1
crossref_primary_10_1016_S1062_1458_00_00157_4
crossref_primary_10_1097_00004872_200201000_00009
crossref_primary_10_1097_01_hjh_0000209985_66853_1e
crossref_primary_10_1016_j_jacc_2005_04_040
crossref_primary_10_1111_j_1523_1755_2004_00626_x
crossref_primary_10_1038_oby_2004_154
crossref_primary_10_1016_j_ahj_2004_03_025
crossref_primary_10_1016_j_atherosclerosis_2013_04_025
crossref_primary_10_1016_j_mcna_2005_05_003
crossref_primary_10_1161_HYPERTENSIONAHA_114_03476
crossref_primary_10_1038_s41440_022_01096_8
crossref_primary_10_1007_s11906_011_0197_8
crossref_primary_10_1053_j_ajkd_2003_12_036
crossref_primary_10_1080_10641960802409846
crossref_primary_10_1371_journal_pone_0107888
crossref_primary_10_1073_pnas_0707791104
crossref_primary_10_1111_j_1527_5299_2003_00798_x
crossref_primary_10_1186_s12889_022_13166_0
crossref_primary_10_1097_00004872_200208000_00020
crossref_primary_10_1016_j_mcna_2004_12_001
crossref_primary_10_1016_S0271_5317_02_00494_3
crossref_primary_10_1097_HJH_0b013e3282f03597
Cites_doi 10.1038/327524a0
10.1161/hyp.28.3.335
10.1161/hyp.27.3.643
10.1161/res.65.1.2544316
10.1016/0140-6736(92)90865-Z
10.1038/ki.1994.316
10.1161/circ.96.4.1282
10.1042/bj1540179
10.1161/hyp.25.6.1220
10.1161/01.hyp.9.2.157
10.1111/j.1476-5381.1994.tb13026.x
10.1161/hyp.29.1.242
10.1172/JCI114081
10.1038/ki.1994.98
10.3109/10623329309102688
10.1161/res.71.2.1628401
10.1161/hyp.31.4.918
10.1161/hyp.27.1.32
10.1016/S0008-6363(97)00242-3
10.1093/cvr/27.7.1380
10.1172/JCI115467
10.1161/hyp.30.6.1628
10.1161/circ.97.22.2222
10.1161/circ.95.8.2068
10.1016/S0021-9258(18)62716-4
10.1097/00004872-199715080-00015
10.1161/01.hyp.22.6.812
10.1016/S0024-3205(98)00225-2
10.1161/01.hyp.12.2.96
10.1007/BF00944786
10.1152/ajpregu.1998.275.5.R1667
ContentType Journal Article
Copyright 2000 INIST-CNRS
Copyright American Heart Association, Inc. Feb 29, 2000
Copyright_xml – notice: 2000 INIST-CNRS
– notice: Copyright American Heart Association, Inc. Feb 29, 2000
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
K9.
NAPCQ
U9A
7X8
DOI 10.1161/01.CIR.101.8.856
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Career and Technical Education (Alumni Edition)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
CrossRef
ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1524-4539
EndPage 861
ExternalDocumentID 53911975
10694524
1284313
10_1161_01_CIR_101_8_856
Genre Journal Article
Comparative Study
GroupedDBID ---
.-D
.3C
.55
.GJ
.XZ
.Z2
01R
0R~
0ZK
18M
1J1
29B
2FS
2WC
354
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
6PF
71W
77Y
7O~
AAAAV
AAAXR
AAFWJ
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AARTV
AASOK
AAUEB
AAWTL
AAXQO
AAYOK
AAYXX
ABBUW
ABDIG
ABJNI
ABOCM
ABPMR
ABPXF
ABQRW
ABXVJ
ABZAD
ACCJW
ACDDN
ACDOF
ACEWG
ACGFO
ACGFS
ACILI
ACOAL
ACRKK
ACWDW
ACWRI
ACXNZ
ACZKN
ADBBV
ADCYY
ADFPA
ADGGA
ADHPY
ADNKB
AE3
AE6
AEETU
AENEX
AFCHL
AFDTB
AFEXH
AFFNX
AFNMH
AFUWQ
AGINI
AHMBA
AHOMT
AHQNM
AHRYX
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
ALKUP
ALMA_UNASSIGNED_HOLDINGS
AMJPA
AMNEI
ASPBG
AVWKF
AYCSE
AZFZN
BAWUL
BOYCO
BQLVK
BS7
BYPQX
C1A
C45
CITATION
CS3
DIK
DIWNM
DU5
DUNZO
E3Z
EBS
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FW0
GX1
H0~
H13
HZ~
H~9
IKREB
IN~
J5H
JF9
JG8
JK3
JK8
K-A
K-F
K8S
KD2
KMI
KQ8
L-C
L7B
M18
N4W
N9A
NEJ
N~7
N~B
N~M
O9-
OAG
OAH
OBH
OCB
OCUKA
ODA
ODMTH
OGEVE
OHH
OHT
OHYEH
OK1
OL1
OLB
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWBYB
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P2P
PQQKQ
R58
RAH
RLZ
S4R
S4S
T8P
TEORI
TR2
UPT
V2I
VVN
W2D
W3M
W8F
WH7
WOQ
WOW
X3V
X3W
X7M
XXN
XYM
YFH
YOC
YQJ
YSK
YYM
YYP
YZZ
ZFV
ZGI
ZXP
ZY1
ZZMQN
~H1
1CY
41~
AAEJM
AAQKA
AASCR
AASXQ
ABASU
ABVCZ
ABXYN
ABZZY
ACLDA
ACXJB
AEBDS
AFBFQ
AFMBP
AFSOK
AHQVU
AJJEV
AKCTQ
AKULP
ALMTX
AMKUR
AOHHW
AOQMC
E.X
EEVPB
EJD
ERAAH
FEDTE
FL-
GNXGY
GQDEL
HLJTE
HVGLF
IKYAY
IPNFZ
IQODW
MVM
P-K
RIG
TSPGW
WHG
YXB
ACIJW
AWKKM
CGR
CUY
CVF
ECM
EIF
NPM
OJAPA
OLW
PKN
RHF
K9.
NAPCQ
U9A
7X8
ADKSD
ID FETCH-LOGICAL-c392t-98c29ac310dd81cca0f2c47e87e45155c9846eccbc1afc9c015dc89314312ab83
ISSN 0009-7322
1524-4539
IngestDate Mon Sep 08 10:08:38 EDT 2025
Fri Jul 25 03:41:24 EDT 2025
Wed Feb 19 02:34:41 EST 2025
Mon Jul 21 09:14:48 EDT 2025
Thu Apr 24 23:11:00 EDT 2025
Tue Jul 01 03:20:07 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Human
Hypertension
Sensitivity
Sodium
Pathogenesis
Nitric oxide
Nitrites
Cardiovascular disease
Nitrates
Blood plasma
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c392t-98c29ac310dd81cca0f2c47e87e45155c9846eccbc1afc9c015dc89314312ab83
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
content type line 23
PMID 10694524
PQID 212757642
PQPubID 24119
PageCount 6
ParticipantIDs proquest_miscellaneous_70959467
proquest_journals_212757642
pubmed_primary_10694524
pascalfrancis_primary_1284313
crossref_citationtrail_10_1161_01_CIR_101_8_856
crossref_primary_10_1161_01_CIR_101_8_856
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2000-02-29
PublicationDateYYYYMMDD 2000-02-29
PublicationDate_xml – month: 02
  year: 2000
  text: 2000-02-29
  day: 29
PublicationDecade 2000
PublicationPlace Hagerstown, MD
PublicationPlace_xml – name: Hagerstown, MD
– name: United States
– name: Baltimore
PublicationTitle Circulation (New York, N.Y.)
PublicationTitleAlternate Circulation
PublicationYear 2000
Publisher Lippincott Williams & Wilkins
American Heart Association, Inc
Publisher_xml – name: Lippincott Williams & Wilkins
– name: American Heart Association, Inc
References (e_1_3_1_26_2) 1993; 264
e_1_3_1_21_2
e_1_3_1_22_2
e_1_3_1_23_2
e_1_3_1_24_2
e_1_3_1_8_2
e_1_3_1_7_2
e_1_3_1_9_2
e_1_3_1_20_2
e_1_3_1_4_2
e_1_3_1_29_2
e_1_3_1_3_2
e_1_3_1_5_2
e_1_3_1_25_2
(e_1_3_1_6_2) 1993; 91
e_1_3_1_2_2
e_1_3_1_27_2
e_1_3_1_1_2
e_1_3_1_28_2
e_1_3_1_32_2
e_1_3_1_33_2
e_1_3_1_34_2
e_1_3_1_13_2
e_1_3_1_12_2
e_1_3_1_11_2
e_1_3_1_30_2
e_1_3_1_10_2
e_1_3_1_31_2
e_1_3_1_17_2
e_1_3_1_16_2
e_1_3_1_15_2
e_1_3_1_14_2
e_1_3_1_19_2
e_1_3_1_18_2
References_xml – ident: e_1_3_1_1_2
  doi: 10.1038/327524a0
– ident: e_1_3_1_9_2
  doi: 10.1161/hyp.28.3.335
– ident: e_1_3_1_16_2
  doi: 10.1161/hyp.27.3.643
– ident: e_1_3_1_3_2
  doi: 10.1161/res.65.1.2544316
– ident: e_1_3_1_12_2
  doi: 10.1016/0140-6736(92)90865-Z
– ident: e_1_3_1_5_2
  doi: 10.1038/ki.1994.316
– ident: e_1_3_1_32_2
  doi: 10.1161/circ.96.4.1282
– ident: e_1_3_1_34_2
  doi: 10.1042/bj1540179
– ident: e_1_3_1_17_2
  doi: 10.1161/hyp.25.6.1220
– ident: e_1_3_1_21_2
  doi: 10.1161/01.hyp.9.2.157
– ident: e_1_3_1_33_2
  doi: 10.1111/j.1476-5381.1994.tb13026.x
– ident: e_1_3_1_15_2
  doi: 10.1161/hyp.29.1.242
– ident: e_1_3_1_2_2
  doi: 10.1172/JCI114081
– volume: 91
  start-page: 1993
  year: 1993
  ident: e_1_3_1_6_2
  publication-title: J Clin Invest
– ident: e_1_3_1_14_2
  doi: 10.1038/ki.1994.98
– ident: e_1_3_1_10_2
  doi: 10.3109/10623329309102688
– ident: e_1_3_1_7_2
  doi: 10.1161/res.71.2.1628401
– ident: e_1_3_1_25_2
  doi: 10.1161/hyp.31.4.918
– ident: e_1_3_1_18_2
  doi: 10.1161/hyp.27.1.32
– ident: e_1_3_1_28_2
  doi: 10.1016/S0008-6363(97)00242-3
– ident: e_1_3_1_11_2
  doi: 10.1111/j.1476-5381.1994.tb13026.x
– ident: e_1_3_1_4_2
  doi: 10.1093/cvr/27.7.1380
– ident: e_1_3_1_22_2
  doi: 10.1172/JCI115467
– ident: e_1_3_1_19_2
  doi: 10.1161/hyp.30.6.1628
– ident: e_1_3_1_20_2
  doi: 10.1161/circ.97.22.2222
– ident: e_1_3_1_31_2
  doi: 10.1161/circ.95.8.2068
– ident: e_1_3_1_13_2
  doi: 10.1016/S0021-9258(18)62716-4
– ident: e_1_3_1_29_2
  doi: 10.1097/00004872-199715080-00015
– ident: e_1_3_1_23_2
  doi: 10.1161/01.hyp.22.6.812
– ident: e_1_3_1_30_2
  doi: 10.1016/S0024-3205(98)00225-2
– ident: e_1_3_1_8_2
  doi: 10.1161/01.hyp.12.2.96
– ident: e_1_3_1_27_2
  doi: 10.1007/BF00944786
– ident: e_1_3_1_24_2
  doi: 10.1152/ajpregu.1998.275.5.R1667
– volume: 264
  start-page: H1535
  year: 1993
  ident: e_1_3_1_26_2
  publication-title: Am J Physiol
SSID ssj0006375
Score 2.1205618
Snippet Background —High salt intake suppresses the effect of nitric oxide (NO) in the peripheral resistance vessels in animal models. We tested the hypothesis that...
High salt intake suppresses the effect of nitric oxide (NO) in the peripheral resistance vessels in animal models. We tested the hypothesis that the modulation...
BACKGROUND: High salt intake suppresses the effect of nitric oxide (NO) in the peripheral resistance vessels in animal models. We tested the hypothesis that...
SourceID proquest
pubmed
pascalfrancis
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 856
SubjectTerms Adult
Aged
Arginine - analogs & derivatives
Arginine - blood
Arterial hypertension. Arterial hypotension
Biological and medical sciences
Blood and lymphatic vessels
Blood Pressure - drug effects
Cardiology. Vascular system
Clinical manifestations. Epidemiology. Investigative techniques. Etiology
Electrolytes - blood
Female
Humans
Hypertension - blood
Hypertension - classification
Hypertension - etiology
Hypertension - physiopathology
Lipids - blood
Male
Medical sciences
Middle Aged
Nitrates - blood
Nitric Oxide - antagonists & inhibitors
Nitric Oxide - blood
Nitrites - blood
Norepinephrine - blood
Renin - blood
Smoking - blood
Sodium Chloride, Dietary - administration & dosage
Sodium Chloride, Dietary - pharmacology
Vascular Resistance - drug effects
Subtitle Modulation of Nitric Oxide Synthesis by Salt Intake
Title Study on the Relationship Between Plasma Nitrite and Nitrate Level and Salt Sensitivity in Human Hypertension
URI https://www.ncbi.nlm.nih.gov/pubmed/10694524
https://www.proquest.com/docview/212757642
https://www.proquest.com/docview/70959467
Volume 101
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBahhTEYo2u3Neu66WEMRnAaX2LZezPdStKSlrUJ65uRZZmZpXZJHFj3c_aL9pN2dPEty64vxiiRbDifz_kkfToHoVdOZJsOdxMj9ikxHM90DY8KLHObc-4Ti8vzFZNzdzRzTq-H153O94ZqaVVEffZ147mS_7EqtIFdxSnZf7BsNSg0wD3YF65gYbj-lY2vVEZopVRclLK2lvwKyPEN7cF3uwBuKXcKxD0QzN5cyIVky5LOi95SKNl1KYk007X7PsEsdSE17koBMsljXe5LCkDEqKyXf0ljLlIfwFuI9CZAaOWIaVbQz-1UCOmClf03VAFqrEqczE7HH4PLoLVZdHEVnAfjlrL7DGLGu2CtaXoxqlvKFY2BPCFe-81NmSnkikY6F7Khljf3DWJbbW-u10YUbL2Gb_aGbjPMqxzwP0cQ15SnIvrH40uxtNH3-lXHZrLutSBaSRtFvLdFGeVtixApHDj7UOevd20yLGv7iTcvN85d82j9kS2i9OCWLuGbTVSxlV_PhiQrmu6gh3o6gwOFzUeow7NdtBdktMhv7vBrLAXGcudmF92baB3HHvomkYvzDANmcBO5WCMXK-RijVwMOMUauVgiV7YInOEGcnGaYYlc3ETuW1zjFueJGpNhiVtc4RZHd2o8hdvHaHbyfno8MnS1EIMBxy8M32OWTxlMV-LYM8ExDRKLOYR7hDuijhHzgWqDw4qYSRPmM-DBMQO2DhMG06KRZz9BW1me8X2EowGhfkziiHLiiKR_wGtj34P4B-EridwuOipNEzKdSl9UdJmHckrtmuHADMGYQj8ZeiEYs4veVD1uVRqZ3_z3sGXtuoOCVhcdlNYPtTNahrJQA3Edq4teVr9CpBDbfzTj-WoZErHkD7yoi54qyDTexPWdoeU8-8OTD9D9-nt9jraKxYofAicvohcS5j8ABVvk2w
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Study+on+the+relationship+between+plasma+nitrite+and+nitrate+level+and+salt+sensitivity+in+human+hypertension%3A+Modulation+of+nitric+oxide+synthesis+by+salt+intake&rft.jtitle=Circulation+%28New+York%2C+N.Y.%29&rft.au=FUJIWARA%2C+N&rft.au=OSANAI%2C+T&rft.au=KAMADA%2C+T&rft.au=KATOH%2C+T&rft.date=2000-02-29&rft.pub=Lippincott+Williams+%26+Wilkins&rft.issn=0009-7322&rft.volume=101&rft.issue=8&rft.spage=856&rft.epage=861&rft_id=info:doi/10.1161%2F01.CIR.101.8.856&rft.externalDBID=n%2Fa&rft.externalDocID=1284313
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-7322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-7322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-7322&client=summon